Company Description
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People’s Republic of China.
The company offers class I, II, and III disposable medical devices. Its products include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; and disposable full anesthesia kits, medical brushes, woman’s examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation kits, medical masks, anal bags, and suction connecting tubes.
It also provides disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies.
It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People’s Republic of China.
Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
| Country | China |
| Founded | 1990 |
| IPO Date | Feb 16, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 617 |
| CEO | Wang Xin |
Contact Details
Address: 88 Tongda Road, Touqiao Town Yangzhou, 225000 China | |
| Phone | 86 051 4898 00199 |
| Website | meihuamed.com |
Stock Details
| Ticker Symbol | MHUA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001835615 |
| CUSIP Number | G5966G108 |
| ISIN Number | KYG5966G1082 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Wang Xin | Chief Executive Officer and Director |
| Lianzhang Zhao | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | 6-K | Report of foreign issuer |
| Oct 7, 2024 | 6-K | Report of foreign issuer |
| Sep 20, 2024 | 6-K | Report of foreign issuer |
| Jul 1, 2024 | 6-K | Report of foreign issuer |
| Jun 11, 2024 | 6-K | Report of foreign issuer |
| Apr 30, 2024 | 424B3 | Prospectus |
| Apr 24, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Apr 24, 2024 | 6-K | Report of foreign issuer |
| Apr 3, 2024 | 6-K | Report of foreign issuer |